3 completed, 1 recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Reamberin: new trials by email Literature Review of Reamberin trials Research Report on Reamberin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis Reamberin, Placebo - Diabetic Ketoacidosis | Phase 2 / Phase 3 | Recruiting | POLYSAN Scientific & Technological Pharmaceutical Company | 312 | 2025-05-01 | 2025-06-24 |
| Study of Safety and Efficiency of the Drug Reamberin® in the Intensive Care of Patients With Acute Ethanol Intoxication Reamberin - Ethanol Intoxication | Completed | POLYSAN Scientific & Technological Pharmaceutical Company | 296 | 2022-09-15 | 2025-04-18 | |
| Meglimine Sodium Succinate for Correction of Metabolic Acidosis in Critically Ill Patients Meglumine Sodium Succinate, Placebo - Metabolic Acidosis | Phase 2 | Completed | POLYSAN Scientific & Technological Pharmaceutical Company | 140 | 2021-06-16 | 2022-10-05 |
| Correction of Metabolic Disorders and Its Effect on Respiratory Function of Lungs in Patients With Severe COVID-19 Reamberin, Ringer's solution - COVID-19 | Completed | POLYSAN Scientific & Technological Pharmaceutical Company | 105 | 2020-12-01 | 2024-12-19 |
Acidosis (1) · COVID-19 (1) · Critical Illness (1) · Diabetic Ketoacidosis (1) · Metabolic Diseases (1)
POLYSAN Scientific & Technological Pharmaceutical Company (4)
Russia (4)
Mikhail Yu Kirov (1) · Tatiana Kharitonova, MD, PhD (1)